ClinicalTrials.gov
ClinicalTrials.gov Menu

Sentinel Node With Ultrasound Contrast in Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00370136
Recruitment Status : Completed
First Posted : August 30, 2006
Last Update Posted : June 18, 2008
Sponsor:
Information provided by:
Rigshospitalet, Denmark

Brief Summary:

The purpose is to evaluate,in 20 patients, if the sentinel node(s) in melanoma can be detected by lymph contrast ultrasound. In comparing the patients will also get lymph-scintigraphy and sentinel node detection wiht blue dye.

The goal is to improve the method for detecting sentinel node(s) in melanoma.


Condition or disease Intervention/treatment Phase
Malignant Melanoma Drug: ultrasound contrast Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Diagnostic
Official Title: Sentinel Node Diagnostics With Ultrasound Contrast in Melanoma
Study Start Date : August 2006
Primary Completion Date : March 2008
Study Completion Date : April 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Melanoma Ultrasound
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Malignant melanoma on a extremity,
  • No spread of the cancer,
  • Patients over 18 years old,

Exclusion Criteria:

  • Pregnancy,
  • Lactating,
  • Severe hart disease,

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00370136


Locations
Denmark
Copenhagen univercity hospital, Department of Radiology, section of ultrasound
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Michael B Nielsen, MDSc Department of Radiology, section ultrasound

ClinicalTrials.gov Identifier: NCT00370136     History of Changes
Other Study ID Numbers: (KF)01288200
First Posted: August 30, 2006    Key Record Dates
Last Update Posted: June 18, 2008
Last Verified: June 2008

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas